Suchergebnisse
UB Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Gefunden in
Art der Quelle
Schlagwort
- medical research 19 Treffer
- medicine, experimental 15 Treffer
- clinical trials 13 Treffer
- covid-19 11 Treffer
- contract manufacturing 9 Treffer
-
45 weitere Werte:
- business 8 Treffer
- london stock exchange plc -- contracts 7 Treffer
- securities industry 7 Treffer
- securities industry -- contracts 7 Treffer
- news, opinion and commentary 6 Treffer
- public health 6 Treffer
- antiviral agents 5 Treffer
- pharmaceutical industry -- contracts 5 Treffer
- biological products industry -- contracts 4 Treffer
- business, international 4 Treffer
- arts centers 3 Treffer
- company growth 3 Treffer
- growth 3 Treffer
- health 3 Treffer
- industrial research -- azerbaijan 3 Treffer
- research and development 3 Treffer
- technology 3 Treffer
- banking, finance and accounting industries 2 Treffer
- computers -- services 2 Treffer
- human challenge trials 2 Treffer
- information technology services 2 Treffer
- ppd inc. -- contracts 2 Treffer
- precision medicine 2 Treffer
- united states. national institute of allergy and infectious diseases 2 Treffer
- achievements and awards 1 Treffer
- biotechnology 1 Treffer
- biotechnology industry 1 Treffer
- business.industry 1 Treffer
- chronic diseases 1 Treffer
- consulting services -- contracts 1 Treffer
- cooperative behavior 1 Treffer
- core competency 1 Treffer
- developing country 1 Treffer
- drug industry 1 Treffer
- drugs 1 Treffer
- epidemics 1 Treffer
- flexibility (engineering) 1 Treffer
- general pharmacology, toxicology and pharmaceutics 1 Treffer
- humans 1 Treffer
- immunology 1 Treffer
- industry forecasts 1 Treffer
- marketing 1 Treffer
- medicine 1 Treffer
- orphan drugs 1 Treffer
- pharmaceutical industry 1 Treffer
Verlag
Publikation
- plus company updates 13 Treffer
- pr newswire 8 Treffer
- contify life science news 3 Treffer
- professional services close-up 3 Treffer
- globenewswire 2 Treffer
-
16 weitere Werte:
- m2 equitybites (eqb) 2 Treffer
- m2 pharma 2 Treffer
- proactive investors united kingdom 2 Treffer
- states news service 2 Treffer
- tendersinfo news 2 Treffer
- biotech week 1 Treffer
- business wire 1 Treffer
- clinical trials week 1 Treffer
- entertainment close-up 1 Treffer
- european union news 1 Treffer
- financial services monitor worldwide 1 Treffer
- global data news 1 Treffer
- human vaccines 1 Treffer
- m2 presswire 1 Treffer
- mena report 1 Treffer
- wireless news 1 Treffer
Sprache
50 Treffer
-
In: European Union News, 2024-06-03ZeitungsartikelZugriff:
-
In: Plus Company Updates, 2022-05-14ZeitungsartikelZugriff:
-
In: Plus Company Updates, 2022-04-12ZeitungsartikelZugriff:
-
In: Financial Services Monitor Worldwide, 2022-04-12ZeitungsartikelZugriff:
-
In: GlobeNewswire, 2022-04-11ZeitungsartikelZugriff:
-
In: Plus Company Updates, 2022-04-09ZeitungsartikelZugriff:
-
In: Business Wire, 2022-04-08ZeitungsartikelZugriff:
-
In: M2 Presswire, 2022-04-05ZeitungsartikelZugriff:
-
In: Biotech Week, 2013-04-10, S. 1487ZeitungsartikelZugriff:
-
In: PR Newswire, 2015-02-23ZeitungsartikelZugriff:
-
In: GlobeNewswire, 2024-04-04ZeitungsartikelZugriff:
-
In: PR Newswire, 2024-02-26ZeitungsartikelZugriff:
-
Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster VaccinesIn: Plus Company Updates, 2023-08-29ZeitungsartikelZugriff:
-
Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster VaccinesIn: PR Newswire, 2023-08-28ZeitungsartikelZugriff:
-
Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster VaccinesIn: M2 EquityBites (EQB), 2023-08-29ZeitungsartikelZugriff:
-
Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster VaccinesIn: M2 Pharma, 2023-08-29ZeitungsartikelZugriff:
-
In: M2 EquityBites (EQB), 2023-01-04ZeitungsartikelZugriff:
-
In: M2 Pharma, 2023-01-04ZeitungsartikelZugriff:
-
In: Human vaccines, Jg. 4 (2008-04-05), Heft 2Online unknownZugriff:
-
In: Plus Company Updates, 2021-05-10ZeitungsartikelZugriff: